Pharmafile Logo

Recordati SpA

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Recordati SpA in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Recordati SpA.

Recent articles on PMLiVE featuring Recordati SpA

- PMLiVE
CHMP backs Sanofi’s all-oral sleeping sickness drug

Sanofi’s drug and others given green light by EMA committee

The good, the bad and the ugly

Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 – it’s a trilogy of trends

Deal Watch July 2016

Real deals, real money and – for some – reality bites

- PMLiVE
Takeda grows in Turkey with Neutec subsidiary acquisition

Will acquire Toplam Kalite for up to 300m Turkish lira

- PMLiVE
Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

Deal Watch table for February 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Recordati completes acquisition of Laboratorios Casen Fleet

Concludes €93m deal for Spanish gastroenterology specialist

Deal Watch table for September 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Deal Watch table for July 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE
Italian pharma market set for continued downturn

Will fall $1.6bn in value by 2020, says analyst GlobalData

Pharma deals during December 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Data provided by GlobalData

GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.

Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.

To find out more about how our research and insights can help you, please visit  https://www.globaldata.com/who-we-are/why-globaldata/

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links